Drugs / rdESAT-6 + rCFP-10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00793702 | Nov 2008 → Jul 2009 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rdESAT-6 + rCFP-10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00793702 ↗ |
| Modality | Diagnostic / imaging agent | “recombinant skin test reagent consisting of a 1ratio1 wt/wt of rdESAT-6 and CFP-10” PMID 20593018 ↗ Jun 2010 |